TGFB1 and glioblastoma: In addition, pharmaceutically targeting the αv integrin/TGF-β axis in combination with allogeneic NK cells in a glioblastoma stem cell (GSC)-engrafted mouse model promotes the antitumor function of NK cells and tumor growth (120).